This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Suncadia Pharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Biao He: Innovator in Pharmaceutical Chemistry
Introduction
Biao He is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Ticagrelor, a medication used to reduce the risk of heart attacks and strokes.
Latest Patents
Biao He holds a patent for the "Intermediate of Ticagrelor and preparation method therefor." This patent discloses intermediates of Ticagrelor and a preparation method for the drug. Specifically, it introduces a compound of Formula (VI) that is essential for preparing Ticagrelor. The method described simplifies the synthesis process, avoiding the long reaction times and high temperatures required in existing methods. This innovation is suitable for mass production, reduces energy consumption, minimizes environmental pollution, and decreases waste discharge.
Career Highlights
Throughout his career, Biao He has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Suncadia Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in drug development and production.
Collaborations
Biao He has collaborated with notable professionals in his field, including Shaoguang Sun and Defu Song. These partnerships have fostered innovation and enhanced the research and development processes in pharmaceutical chemistry.
Conclusion
Biao He is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative approach to the preparation of Ticagrelor showcases his commitment to improving drug synthesis and production methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile